This announcement is a separate document:
百奧賽圖-B：自願公告IDEAYA提名具有同類首創潛力的B7H3/PTK7拓撲異構酶抑制劑有效載荷雙特異性ADC (IDE034)作為開發候選藥物並行使選擇權
BIOCYTOGEN-B: VOLUNTARY ANNOUNCEMENTIDEAYA'S NOMINATION OF DEVELOPMENT CANDIDATE IDE034,A POTENTIAL FIRST-IN-CLASS B7H3/PTK7 TOPO-I-PAYLOADBISPECIFIC ADC AND OPTION EXERCISE
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.